Helius Medical Technologies is trading 5.76% down at $2.29 after closing August 27, 2026, at $2.43, despite an 18.54% regular-session gain; no fresh company-specific catalyst was identified.
- Recent coverage centers on its August 14 quarterly results and August 21 Solana governance positions, not a fresh after-hours event.
- The broader market was risk-on and does not clearly explain the contrary decline.